VIP and colon adenocarcinoma: In clinical studies, radiolabeled-VIP binds VPAC and detects primary and metastatic tumors in a variety of cancer histologies [12,13], and serum VIP levels are > two-fold higher in patients with colon adenocarcinoma [14,15].